Illuminate Therapeutics, Inc.
Menlo Park, CA
- UEI
- WVLWH6J17CP5
- CAGE
- 9HSL5
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 16 Aliso Way, Menlo Park, CA 94028, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i: the laddr platform for precise delivery of nucleic acid therapy for head and neck cancer and esophageal… | National Science Foundation | $275,000 |
Quick answers
What is Illuminate Therapeutics, Inc.'s UEI?
Illuminate Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is WVLWH6J17CP5.
What is Illuminate Therapeutics, Inc.'s CAGE code?
Illuminate Therapeutics, Inc.'s CAGE code is 9HSL5.
What is Illuminate Therapeutics, Inc.'s primary NAICS code?
Illuminate Therapeutics, Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).
Where is Illuminate Therapeutics, Inc. located?
Illuminate Therapeutics, Inc.'s physical address in SAM.gov is 16 Aliso Way, Menlo Park, CA 94028, USA.
Is Illuminate Therapeutics, Inc. registered in SAM.gov?
Yes. Illuminate Therapeutics, Inc.'s SAM.gov registration is active through March 18, 2027.
What is Illuminate Therapeutics, Inc.'s most recent federal award?
Illuminate Therapeutics, Inc.'s most recent federal grant award is Sbir phase i: the laddr platform for precise delivery of nucleic acid therapy for head and neck cancer and esophageal… (2432864), from National Science Foundation, on September 1, 2024.
On GovTribe
See Illuminate Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors